Skip to content

Direct Inject 79-45910Recalls & reported problems

Stryker Leibinger GmbH & Co. KG · DirectInject On-Demand HA Cement · Class 2 · Implant

All models of Direct Inject (3)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 07613327123272), received between Oct 19, 2018 and Jul 31, 2024 — classified as 5 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K143661); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5
  • Device Appears to Trigger Rejection2
  • Fracture2
  • Migration1

Patient problems

  • Inflammation2
  • Swelling/ Edema2
  • Cerebrospinal Fluid Leakage1
  • Failure of Implant1
  • Foreign Body In Patient1
  • No Consequences Or Impact To Patient1
  • No Known Impact Or Consequence To Patient1
  • Pain1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 31, 2024Fracture; Adverse Event Without Identified Device or Use Problem; Fracture; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED TO STRYKER THAT THE PATIENT BEGAN EXPERIENCING DISCOMFORT FOUR YEARS AFTER THE MATERIAL WAS INSERTED. IT WAS REPORTED THERE WAS INFLAMMATORY REACTIONS AND SWELLING. A POST OPERATIVE SCAN WAS PERFORMED AND SHOWED THAT THE SWELLING WAS DUE TO THE IMPLANT INSERTED AND A REVISION SURGERY WAS PERFORMED TO REMOVE THE IMPLANT.

    Patient problems: Failure of Implant; Inflammation; Pain; Swelling/ Edema

    MAUDE report 19876295 ↗
  • InjuryNov 24, 2021Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem; Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THERE WAS CLEAR FLUID ACCUMULATION AFTER USE OF DIRECTINJECT BONE CEMENT. A REVISION SURGERY WAS CONDUCTED. NO FURTHER INFORMATION IS KNOWN AT THIS TIME.

    Patient problems: Swelling/ Edema

    MAUDE report 12867775 ↗
  • InjuryNov 23, 2021Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem; Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THERE WAS CLEAR FLUID ACCUMULATION AFTER USE OF DIRECTINJECT BONE CEMENT. A REVISION SURGERY WAS CONDUCTED. NO FURTHER INFORMATION IS KNOWN AT THIS TIME.

    Patient problems: Inflammation

    MAUDE report 12865611 ↗
  • MalfunctionMay 18, 2020Migration; Migration

    IT WAS REPORTED TO US THAT THE PRODUCT WAS USED AT THE TIME OF CLOSING THE BURR HOLE AND THE ARTIFICIAL BONE HAD FALLEN INTO THE DURA POST OPERATIVELY. IT WAS REPORTED THERE WAS NO INJURY TO THE PATIENT.

    Patient problems: Foreign Body In Patient

    MAUDE report 10065093 ↗
  • MalfunctionJan 8, 2020Fracture; Fracture

    IT WAS REPORTED BY THE COMPANY REPRESENTATIVE THAT WHILE THE SURGEON WAS SQUEEZING OUT DIRECT INJECT, THE TIP OF THE APPLICATOR BROKE, CAUSING THE CONTENTS TO SPILL OUT. BACK UP DIRECT INJECT WAS AVAILABLE AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY.

    Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient

    MAUDE report 9565123 ↗
  • InjuryJun 10, 2019Adverse Event Without Identified Device or Use Problem

    CUSTOMER HAD A CRANIOTOMY AND HAD TO GET A REVISION SURGERY DUE TO A CSF LEAK. CUSTOMER SAID THERE IS NOT A DIRECT PRODUCT COMPLAINT.

    Patient problems: Cerebrospinal Fluid Leakage

    MAUDE report 8684748 ↗
  • InjuryOct 19, 2018Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT UNDERWENT SURGERY IN (B)(6) 2017 - DIRECT INJECT WAS USED. NOW, THE PATIENT HAS PRESENTED WITH A REACTION.

    Patient problems: Reaction

    MAUDE report 7985840 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K143661. One submission often covers many models, so check the product and lot details in each record.

  • Z-1436-2021 · Apr 1, 2021 · Terminated
    DirectInject consists of a sterile dual paste system which is calcium phosphate based. Upon injection through the Mixer-Cannula, the two pastes form a cement paste which is moldabl

Other METHYL METHACRYLATE FOR CRANIOPLASTY devices

All METHYL METHACRYLATE FOR CRANIOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page